Log in

NYSE:TARO - Taro Pharmaceutical Industries Stock Price, Forecast & News

$61.20
-1.29 (-2.06 %)
(As of 04/1/2020 03:56 AM ET)
Today's Range
$60.39
Now: $61.20
$62.64
50-Day Range
$59.35
MA: $67.52
$76.01
52-Week Range
$56.07
Now: $61.20
$109.42
Volume53,682 shs
Average Volume53,822 shs
Market Capitalization$2.34 billion
P/E Ratio9.47
Dividend YieldN/A
Beta0.8
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company sells and distributes its products principally to drug industry wholesalers, drug store chains, mass merchandisers, healthcare institutions, and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Zrt.
Read More
Taro Pharmaceutical Industries logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone972-4847-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$669.89 million
Cash Flow$8.04 per share
Book Value$49.59 per share

Profitability

Net Income$281.78 million

Miscellaneous

Employees1,464
Market Cap$2.34 billion
Next Earnings Date5/27/2020 (Estimated)
OptionableOptionable

Receive TARO News and Ratings via Email

Sign-up to receive the latest news and ratings for TARO and its competitors with MarketBeat's FREE daily newsletter.


Taro Pharmaceutical Industries (NYSE:TARO) Frequently Asked Questions

How has Taro Pharmaceutical Industries' stock been impacted by COVID-19 (Coronavirus)?

Taro Pharmaceutical Industries' stock was trading at $64.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TARO stock has decreased by 5.0% and is now trading at $61.20. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Taro Pharmaceutical Industries?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Taro Pharmaceutical Industries in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Taro Pharmaceutical Industries.

When is Taro Pharmaceutical Industries' next earnings date?

Taro Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Wednesday, May 27th 2020. View our earnings forecast for Taro Pharmaceutical Industries.

How were Taro Pharmaceutical Industries' earnings last quarter?

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced its earnings results on Monday, February, 3rd. The company reported $1.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.54 by $0.22. The company earned $147.68 million during the quarter, compared to analyst estimates of $172 million. Taro Pharmaceutical Industries had a net margin of 38.24% and a return on equity of 12.45%. View Taro Pharmaceutical Industries' earnings history.

What price target have analysts set for TARO?

1 equities research analysts have issued 12 month price objectives for Taro Pharmaceutical Industries' shares. Their forecasts range from $94.00 to $94.00. On average, they expect Taro Pharmaceutical Industries' share price to reach $94.00 in the next year. This suggests a possible upside of 53.6% from the stock's current price. View analysts' price targets for Taro Pharmaceutical Industries.

Has Taro Pharmaceutical Industries been receiving favorable news coverage?

Media coverage about TARO stock has been trending very negative recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Taro Pharmaceutical Industries earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term. View the latest news aboutTaro Pharmaceutical Industries.

Are investors shorting Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries saw a drop in short interest during the month of March. As of March 13th, there was short interest totaling 185,900 shares, a drop of 15.6% from the February 27th total of 220,200 shares. Based on an average daily volume of 52,700 shares, the short-interest ratio is presently 3.5 days. Currently, 2.2% of the company's stock are sold short. View Taro Pharmaceutical Industries' Current Options Chain.

Who are some of Taro Pharmaceutical Industries' key competitors?

What other stocks do shareholders of Taro Pharmaceutical Industries own?

Who are Taro Pharmaceutical Industries' key executives?

Taro Pharmaceutical Industries' management team includes the following people:
  • Mr. Uday V. Baldota, CEO & Director (Age 49)
  • Mr. Mariano Balaguer, CFO, Chief Accounting Officer & VP (Age 46)
  • Mr. Itamar Karsenti, VP & Head of Global Operations (Age 47)
  • Mr. Itzik Baruch, VP of Technical Services (Age 56)
  • Dr. Roman Kaplan Ph.D., VP of Scientific and Technical Compliance Mang. (Age 72)

What is Taro Pharmaceutical Industries' stock symbol?

Taro Pharmaceutical Industries trades on the New York Stock Exchange (NYSE) under the ticker symbol "TARO."

How do I buy shares of Taro Pharmaceutical Industries?

Shares of TARO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Taro Pharmaceutical Industries' stock price today?

One share of TARO stock can currently be purchased for approximately $61.20.

How big of a company is Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries has a market capitalization of $2.34 billion and generates $669.89 million in revenue each year. The company earns $281.78 million in net income (profit) each year or $7.23 on an earnings per share basis. Taro Pharmaceutical Industries employs 1,464 workers across the globe. View additional information about Taro Pharmaceutical Industries.

What is Taro Pharmaceutical Industries' official website?

The official website for Taro Pharmaceutical Industries is http://www.taro.com/.

How can I contact Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries' mailing address is 14 HAKITOR ST PO BOX 10347, HAIFA BAY L3, 10532. The company can be reached via phone at 972-4847-5700 or via email at [email protected]


MarketBeat Community Rating for Taro Pharmaceutical Industries (NYSE TARO)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  243 (Vote Outperform)
Underperform Votes:  303 (Vote Underperform)
Total Votes:  546
MarketBeat's community ratings are surveys of what our community members think about Taro Pharmaceutical Industries and other stocks. Vote "Outperform" if you believe TARO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TARO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel